3,3′-Dinitro-4,4′-hydrazofurazan and methods of preparation
    1.
    发明授权
    3,3′-Dinitro-4,4′-hydrazofurazan and methods of preparation 失效
    3,3'-二硝基-4,​​4'-咔唑和其制备方法

    公开(公告)号:US06388087B1

    公开(公告)日:2002-05-14

    申请号:US09718947

    申请日:2000-11-21

    CPC classification number: C06B25/34 C07D271/08

    Abstract: The novel compound 3,3-Dinitro-4,4′-hydrozofurazan and the methods of preparation. The method of preparation 3,3-Dinitro-4,4′-hydrazofurazan which comprises partially reducing 3,3′-Dinitro-4,4′-azoxyfurazan. The method of preparing 3,3′-Dinitro-4,4′-hydrazofurazan by the partial reduction of 3,3′-Dinitro-4,4′-azofurazan.

    Abstract translation: 新型化合物3,3,3-二硝基-4,​​4'-氢唑唑烷及其制备方法。 制备3,3,3-二硝基-4,​​4'-咔唑的方法,该方法包括部分还原3,3'-二硝基-4,​​4'-氮杂氧杂呋喃。 通过部分还原3,3'-二硝基-4,​​4'-唑烷来制备3,3'-二硝基-4,​​4'-咔唑的方法。

    Preparation of new intermediates and their use in manufacturing of cephalosporin compounds
    3.
    发明授权
    Preparation of new intermediates and their use in manufacturing of cephalosporin compounds 失效
    新中间体的制备及其在制造头孢菌素化合物中的应用

    公开(公告)号:US06384215B1

    公开(公告)日:2002-05-07

    申请号:US09875043

    申请日:2001-06-07

    CPC classification number: C07D271/113 C07D501/00

    Abstract: The present invention provides new thioester derivatives of 4-halogeno-2-methoxyimino-3-oxo-butyric acid of the general formula (I), also, the invention provides a method by which the said thioester derivatives can be prepared by reacting 4-halogeno-2-methoxyimino-3-oxo-butyric acid of the general formula (II) with 2-mercapto-5-substituted-1,3,4-oxadiazoles of the general formula (III) in a solvent, in the presence of DMF/POCl3 and in presence of an organic base and if desired the so obtained thioester derivatives so obtained are reacted with 7-amino-cephem carboxylic acids of the general formula (V) to produce condensed products which are insitu reacted with thiourea to get cephalosporin antibiotic compounds having the general formula (VI).

    Abstract translation: 本发明提供了通式(I)的4-卤代-2-甲氧基亚氨基-3-氧代 - 丁酸的新的硫代酯衍生物,本发明还提供了一种可通过使4- 通式(II)的2-氧代-2-甲氧基亚氨基-3-氧代 - 丁酸与通式(III)的2-巯基-5-取代-1,3,4-恶二唑在溶剂中,在 DMF / POCl 3并在有机碱的存在下,如果需要,如此得到的硫酯类衍生物与通式(Ⅴ)的7-氨基头孢烯羧酸反应,生成与硫脲本身反应得到头孢菌素的缩合产物 具有通式(VI)的抗生素化合物。

Patent Agency Ranking